Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

Observational Study Evaluating the Body Weight Progress During the Treatment With Insulin Detemir (Levemir®) in Type 2 Patients, Previously Treated With Other Basal Insulins

This study is conducted in Europe. Observational study evaluating the body weight progress during the treatment with insulin detemir (Levemir®) in Type 2 patients, previously treated with other basal insulins

Inclusion Criteria:

• Type 2 diabetes
• Current treatment with insulin NPH or glargine
• The selection of the subjects will be at the discretion of the individual physician

Exclusion Criteria:

• Current treatment with insulin detemir
• Previous enrolment in this study
• Hypersensitivity to insulin detemir or to any of the excipients.
• Women who are pregnant, breast feeding or have the intention of becoming pregnant within next 12 months